# US 2003/0224484 A1 · Method and cloning vectors utilizing intergeneric conjugation for manipulation of actinomycetes biosynthesis genes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224484 A1
- Document ID: US20030224484A1
- Status: Published application
- Kind: A1
- Application number: 10/402,841
- Filed: 2003-03-28
- Published: 2003-12-04
- Earliest claimed: 2002-03-29
- Assignees: Wyeth
- Inventors: Nathan Magarvey
- Web page: https://patentgrep.com/patent/US20030224484A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a vector comprising sequences that permit direct transfer of the vector from one prokaryotic cell to another, such as by intergeneric conjugation. The invention also relates to methods of making and using the vector.

## Claims

### Claim 1

A vector comprising a nucleic acid encoding a polypeptide, wherein said nucleic acid is operatively associated with an expression control sequence, an E. coli origin of replication, an actinomycetes origin of replication, a cos cosmid cloning site, and an origin of transfer.

### Claim 2 (depends on 1)

The vector according to claim 1, wherein the vector sequence permits passage of the vector from a first prokaryotic cell to a second prokaryotic cell by direct transfer.

### Claim 3 (depends on 2)

The vector according to claim 2, wherein the direct transfer is by conjugation.

### Claim 4 (depends on 2)

The vector according to claim 2, wherein the E. coli origin of replication is ColE1 and the actinomycetes origin of replication is pJV1.

### Claim 5 (depends on 2)

The vector according to claim 2, wherein the first prokaryotic cell is E. coli.

### Claim 6 (depends on 2)

The vector according to claim 2, wherein the second prokaryotic cell is actinomycetes.

### Claim 7 (depends on 2)

The vector according to claim 2 wherein the second prokaryotic cell is Acetobacter xylinum, Achrombacter parvulus, Acinetobacter spp., Aeromonas spp., Agrobacterium spp., Alcaligenes spp., Anabaena spp., Azospirrillum brazilense, Azotobacter spp., Bordetella spp., Caulobater spp., Enterobacteriaceae, Haemophilus influenzae, Hypomycrobium X, Legionella pneumophila, Methylophilus methyltrophus, ethylosinus trichosporium, Myxococcus xanthus, Neisseria spp., Paracoccus denitrificans, Pseudomonas spp., Rhizobium spp., Rhodopseudomonas spp., Rhodospirillum spp., Thiobacillus spp., Vibrio cholerae, Xanthomonas spp., Yersinia enterocolitica, Myxococcus or Bacteroides.

### Claim 8 (depends on 2)

The vector according to claim 2, wherein the vector has a vector map as depicted in FIG. 1.

### Claim 9 (depends on 2)

A host cell genetically engineered to contain the vector of claim 2.

### Claim 10 (depends on 10)

The host cell of claim 10, wherein the cell is an E. coli.

### Claim 11

A method of expressing a polypeptide in a prokaryotic cell, wherein the method comprises:
(i) culturing a first prokaryotic cell comprising a vector, wherein the vector comprises a nucleic acid encoding the protein, an E. coli origin of replication, an actinomycetes origin of replication, a cos cosmid cloning site, and an origin of transfer, and wherein the vector sequences permit direct transfer from the first prokaryotic cell to a second prokaryotic cell, with a second prokaryotic cell;
(ii) allowing direct transfer of the vector from said first prokaryotic cell to said second prokaryotic cell, wherein the direct transfer occurs by conjugation; and
(iii) expressing the protein in the second prokaryotic cell.

### Claim 12 (depends on 12)

The method according to claim 12, wherein the expressed protein is encoded by a nucleic acid having a modified nucleotide sequence, whereby the expressed protein is a modified protein.

### Claim 13 (depends on 13)

The method according to claim 13, wherein the nucleic acid sequence comprises a modification comprising insertion of a heterologous nucleotide sequence, deletion of a nucleotide sequence, or alteration of a least one nucleotide within the sequence.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the nucleic acid encoding the protein is further incorporated into the second prokaryotic cell genome by homologous recombination.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the vector has a vector map as depicted in FIG. 1.

### Claim 16 (depends on 12)

The method according to claim 12, wherein the first prokaryotic cell is E. coli and the second prokaryotic cell is actinomycetes.

### Claim 17 (depends on 12)

The method according to claim 12 wherein the second prokaryotic cell is a prokaryotic cell which undergoes conjugation.

### Claim 18 (depends on 12)

The method according to claim 12 wherein the second prokaryotic cell is Acetobacter xylinum, Achrombacter parvulus, Acinetobacter spp., Aeromonas spp., Agrobacterium spp., Alcaligenes spp., Anabaena spp., Azospirrillum brazilense, Azotobacter spp., Bordetella spp., Caulobater spp., Enterobacteriaceae, Haemophilus influenzae, Hypomycrobium X, Legionella pneumophila, Methylophilus methyltrophus, Ethylosinus trichosporium, Myxococcus xanthus, Neisseria spp., Paracoccus denitrificans, Pseudomonas spp., Rhizobium spp., Rhodopseudomonas spp., Rhodospirillum spp., Thiobacillus spp., Vibrio cholerae, Xanthomonas spp., Yersinia enterocolitica, Myxococcus or Bacteroides.
